• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Daniel C. Chung, MD


  • Arnason T, Liang WY, Alfaro E, Kelly P, Chung DC, Odze RD, Lauwers GY.Morphology and natural history of familial adenomatous polyposis-associated dysplastic fundic gland polyps.Histopathology. 2014 Feb 18.
  • Richter JM, Pino MS, Austin TR, Campbell E, Szymonifka J, Russo AL, Hong TS, Borger D, Iafrate AJ, Chung DC.Genetic Mechanisms in Interval Colon Cancers.Dig Dis Sci. 2014 Apr 5.
  • Shields HM, Stoffel EM, Chung DC, Sequist TD, Li JW, Pelletier SR, Spencer J, Silk JM, Austin BL, Diguette S, Furbish JE, Lederman R, Weingart SN.Disparities in evaluation of patients with rectal bleeding 40 years and older.Clin Gastroenterol Hepatol. 2014 Apr;12(4):669-75; quiz e33.
  • Gala MK, Mizukami Y, Le LP, Moriichi K, Austin T, Yamamoto M, Lauwers GY, Bardeesy N, Chung DC.Germline mutations in oncogene-induced senescence pathways are associated with multiple sessile serrated adenomas.Gastroenterology. 2014 Feb;146(2):520-9.
  • Ma T, Jang EJ, Zukerberg LR, Odze R, Gala MK, Kelsey PB, Forcione DG, Brugge WR, Casey BW, Syngal S, Chung DC.Recurrences are common after endoscopic ampullectomy for adenoma in the familial adenomatous polyposis (FAP) syndrome.Surg Endosc. 2014 Feb 25.
  • Wang L, Gala M, Yamamoto M, Pino MS, Kikuchi H, Shue DS, Shirasawa S, Austin TR, Lynch MP, Rueda BR, Zukerberg LR, Chung DC.Adrenomedullin is a therapeutic target in colorectal cancer.Int J Cancer. 2014 May 1;134(9):2041-50.
  • Thilly WG, Gostjeva EV, Koledova VV, Zukerberg LR, Chung D, Fomina JN, Darroudi F, Stollar BD.Metakaryotic stem cell nuclei use pangenomic dsRNA/DNA intermediates in genome replication and segregation.Organogenesis. 2014 Jan 13;10(1).
  • Francis JM, Kiezun A, Ramos AH, Serra S, Pedamallu CS, Qian ZR, Banck MS, Kanwar R, Kulkarni AA, Karpathakis A, Manzo V, Contractor T, Philips J, Nickerson E, Pho N, Hooshmand SM, Brais LK, Lawrence MS, Pugh T, McKenna A, Sivachenko A, Cibulskis K, Carter SL, Ojesina AI, Freeman S, Jones RT, Voet D, Saksena G, Auclair D, Onofrio R, Shefler E, Sougnez C, Grimsby J, Green L, Lennon N, Meyer T, Caplin M, Chung DC, Beutler AS, Ogino S, Thirlwell C, Shivdasani R, Asa SL, Harris CR, Getz G, Kulke M, Meyerson M.Somatic mutation of CDKN1B in small intestine neuroendocrine tumors.Nat Genet. 2013 Dec;45(12):1483-6.
  • Kostic AD, Chun E, Robertson L, Glickman JN, Gallini CA, Michaud M, Clancy TE, Chung DC, Lochhead P, Hold GL, El-Omar EM, Brenner D, Fuchs CS, Meyerson M, Garrett WS.Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment.Cell Host Microbe. 2013 Aug 14;14(2):207-15.
  • Arnason T, Pino MS, Yilmaz O, Kirley SD, Rueda BR, Chung DC, Zukerberg LR.Cables1 is a tumor suppressor gene that regulates intestinal tumor progression in Apc(Min) mice.Cancer Biol Ther. 2013 Jul;14(7):672-8.
  • Oberg KE, Casanovas O, Castano JP, Chung DC, Delle Fave G, Denefle P, Harris P, Khan MS, Kulke MH, Scarpa A, Tang LH, Wiedenmann B.Molecular Pathogenesis of Neuroendocrine Tumors: Implications for Current and Future Therapeutic Approaches.Clin Cancer Res. 2013 Mar 4.
  • Yurgelun MB, Mercado R, Rosenblatt M, Dandapani M, Kohlmann W, Conrad P, Blanco A, Shannon KM, Chung DC, Terdiman J, Gruber SB, Garber JE, Syngal S, Stoffel EM.Impact of genetic testing on endometrial cancer risk-reducing practices in women at risk for Lynch syndrome.Gynecol Oncol. 2012 Dec;127(3):544-51.
  • Fujita H, Lennerz JK, Chung DC, Patel D, Deshpande V, Yoon SS, Lauwers GY.Endoscopic Surveillance of Patients With Hereditary Diffuse Gastric Cancer: Biopsy Recommendations After Topographic Distribution of Cancer Foci in a Series of 10 CDH1-mutated Gastrectomies.Am J Surg Pathol. 2012 Nov;36(11):1709-17.
  • Chan AT, Baba Y, Shima K, Nosho K, Chung DC, Hung KE, Mahmood U, Madden K, Poss K, Ranieri A, Shue D, Kucherlapati R, Fuchs CS, Ogino S.Cathepsin B Expression and Survival in Colon Cancer: Implications for Molecular Detection of Neoplasia.Cancer Epidemiol Biomarkers Prev. 2010 Nov;19(11):2777-85.
  • Willett CG, Duda DG, Ancukiewicz M, Shah M, Czito BG, Bentley R, Poleski M, Fujita H, Lauwers GY, Carroll M, Tyler D, Mantyh C, Shellito P, Chung DC, Clark JW, Jain RK.A Safety and Survival Analysis of Neoadjuvant Bevacizumab with Standard Chemoradiation in a Phase I/II Study Compared with Standard Chemoradiation in Locally Advanced Rectal Cancer.Oncologist. 2010;15(8):845-51.
  • Pandalai PK, Lauwers GY, Chung DC, Patel D, Yoon SS.Prophylactic total gastrectomy for individuals with germline CDH1 mutation.Surgery. 2010 Aug 16.
  • Stoffel EM, Mercado RC, Kohlmann W, Ford B, Grover S, Conrad P, Blanco A, Shannon KM, Powell M, Chung DC, Terdiman J, Gruber SB, Syngal S.Prevalence and Predictors of Appropriate Colorectal Cancer Surveillance in Lynch Syndrome.Am J Gastroenterol. 2010 Aug;105(8):1851-60.
  • Manne SL, Meropol NJ, Weinberg DS, Vig H, Catts ZA, Manning C, Ross E, Shannon K, Chung DC.Reply to S. Sciallero et al.J Clin Oncol. 2010 Aug 2.
  • Sasajima J, Mizukami Y, Sugiyama Y, Nakamura K, Kawamoto T, Koizumi K, Fujii R, Motomura W, Sato K, Suzuki Y, Tanno S, Fujiya M, Sasaki K, Shimizu N, Karasaki H, Kono T, Kawabe J, Ii M, Yoshiara H, Kamiyama N, Ashida T, Bardeesy N, Chung DC, Kohgo Y.Transplanting normal vascular proangiogenic cells to tumor-bearing mice triggers vascular remodeling and reduces hypoxia in tumors.Cancer Res. 2010 Aug 1;70(15):6283-92.
  • Pino MS, Chung DC.Application of molecular diagnostics for the detection of Lynch syndrome.Expert Rev Mol Diagn. 2010 Jul;10(5):651-65. Review.
  • Fitzgerald RC, Hardwick R, Huntsman D, Carneiro F, Guilford P, Blair V, Chung DC, Norton J, Ragunath K, Van Krieken JH, Dwerryhouse S, Caldas C, .Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research.J Med Genet. 2010 Jul;47(7):436-44.
  • Jang E, Chung DC.Hereditary colon cancer: lynch syndrome.Gut Liver. 2010 Jun;4(2):151-60.
  • Zeng M, Kikuchi H, Pino MS, Chung DC.Hypoxia activates the K-ras proto-oncogene to stimulate angiogenesis and inhibit apoptosis in colon cancer cells.PLoS ONE. 2010;5(6):e10966.
  • Baba Y, Nosho K, Shima K, Irahara N, Chan AT, Meyerhardt JA, Chung DC, Giovannucci EL, Fuchs CS, Ogino S.HIF1A overexpression is associated with poor prognosis in a cohort of 731 colorectal cancers.Am J Pathol. 2010 May;176(5):2292-301.
  • Pino MS, Chung DC.The chromosomal instability pathway in colon cancer.Gastroenterology. 2010 Jun;138(6):2059-72. Review.
  • Pino MS, Kikuchi H, Zeng M, Herraiz MT, Sperduti I, Berger D, Park DY, Iafrate AJ, Zukerberg LR, Chung DC.Epithelial to Mesenchymal Transition Is Impaired in Colon Cancer Cells With Microsatellite Instability.Gastroenterology. 2010 Apr;138(4):1406-17.
  • Manne SL, Meropol NJ, Weinberg DS, Vig H, Ali-Khan Catts Z, Manning C, Ross E, Shannon K, Chung DC.Facilitating informed decisions regarding microsatellite instability testing among high-risk individuals diagnosed with colorectal cancer.J Clin Oncol. 2010 Mar 10;28(8):1366-72.
  • Nakamura K, Sasajima J, Mizukami Y, Sugiyama Y, Yamazaki M, Fujii R, Kawamoto T, Koizumi K, Sato K, Fujiya M, Sasaki K, Tanno S, Okumura T, Shimizu N, Kawabe J, Karasaki H, Kono T, Ii M, Bardeesy N, Chung DC, Kohgo Y.Hedgehog promotes neovascularization in pancreatic cancers by regulating Ang-1 and IGF-1 expression in bone-marrow derived pro-angiogenic cells.PLoS ONE. 2010;5(1):e8824.
  • Kikuchi H, Pino MS, Zeng M, Shirasawa S, Chung DC.Oncogenic KRAS and BRAF differentially regulate hypoxia-inducible factor-1alpha and -2alpha in colon cancer.Cancer Res. 2009 Nov 1;69(21):8499-506.
  • Xu L, Duda DG, di Tomaso E, Ancukiewicz M, Chung DC, Lauwers GY, Samuel R, Shellito P, Czito BG, Lin PC, Poleski M, Bentley R, Clark JW, Willett CG, Jain RK.Direct evidence that bevacizumab, an anti-VEGF antibody, up-regulates SDF1alpha, CXCR4, CXCL6, and neuropilin 1 in tumors from patients with rectal cancer.Cancer Res. 2009 Oct 15;69(20):7905-10.
  • Greenblatt WH, Hur C, Knudsen AB, Evans JA, Chung DC, Gazelle GS.Cost-effectiveness of prophylactic surgery for duodenal cancer in familial adenomatous polyposis.Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2677-84.
  • Grover S, Stoffel EM, Mercado RC, Ford BM, Kohlman WK, Shannon KM, Conrad PG, Blanco AM, Terdiman JP, Gruber SB, Chung DC, Syngal S.Colorectal cancer risk perception on the basis of genetic test results in individuals at risk for Lynch syndrome.J Clin Oncol. 2009 Aug 20;27(24):3981-6.
  • Benita Y, Kikuchi H, Smith AD, Zhang MQ, Chung DC, Xavier RJ.An integrative genomics approach identifies Hypoxia Inducible Factor-1 (HIF-1)-target genes that form the core response to hypoxia.Nucleic Acids Res. 2009 Aug;37(14):4587-602.
  • Willett CG,Duda DG,di Tomaso E,Boucher Y,Ancukiewicz M,Sahani DV,Lahdenranta J,Chung DC,Fischman AJ,Lauwers GY,Shellito P,Czito BG,Wong TZ,Paulson E,Poleski M,Vujaskovic Z,Bentley R,Chen HX,Clark JW,Jain RK.Efficacy, Safety, and Biomarkers of Neoadjuvant Bevacizumab, Radiation Therapy, and Fluorouracil in Rectal Cancer: A Multidisciplinary Phase II Study.J Clin Oncol. 2009 Jun 20;27(18):3020-6.
  • Bertagnolli MM,Eagle CJ,Zauber AG,Redston M,Breazna A,Kim K,Tang J,Rosenstein RB,Umar A,Bagheri D,Collins NT,Burn J,Chung DC,Dewar T,Foley TR,Hoffman N,Macrae F,Pruitt RE,Saltzman JR,Salzberg B,Sylwestrowicz T,Hawk ET.Five-year efficacy and safety analysis of the Adenoma Prevention with Celecoxib Trial.Cancer Prev Res (Phila Pa). 2009 Apr;2(4):310-21.
  • Pino MS,Mino-Kenudson M,Wildemore BM,Ganguly A,Batten J,Sperduti I,Iafrate AJ,Chung DC.Deficient DNA mismatch repair is common in Lynch syndrome-associated colorectal adenomas.J Mol Diagn. 2009 May;11(3):238-47.
  • Imamura T,Kikuchi H,Herraiz MT,Park DY,Mizukami Y,Mino-Kenduson M,Lynch MP,Rueda BR,Benita Y,Xavier RJ,Chung DC.HIF-1alpha and HIF-2alpha have divergent roles in colon cancer.Int J Cancer. 2009 Feb 15;124(4):763-71.
  • Chung DC.Stool DNA testing and colon cancer prevention: another step forward.Ann Intern Med. 2008 Oct 7;149(7):509-10.
  • Modlin IM,Moss SF,Chung DC,Jensen RT,Snyderwine E.Priorities for improving the management of gastroenteropancreatic neuroendocrine tumors.Journal of the National Cancer Institute. 2008 Sep 17;100(18):1282-9.
  • Fujiki K,Duerr EM,Kikuchi H,Ng A,Xavier RJ,Mizukami Y,Imamura T,Kulke MH,Chung DC.Hoxc6 is overexpressed in gastrointestinal carcinoids and interacts with JunD to regulate tumor growth.Gastroenterology. 2008 Sep;135(3):907-16, 916.e1-2.
  • Sakamoto H, Friel AM, Wood AW, Guo L, Ilic A, Seiden MV, Chung DC, Lynch MP, Serikawa T, Munro E, Oliva E, Orsulic S, Kirley SD, Foster R, Zukerberg LR, Rueda BR.Mechanisms of Cables 1 gene inactivation in human ovarian cancer development.Cancer Biol Ther. 2008 Feb;7(2):180-88.
  • Yamazaki M, Nakamura K, Mizukami Y, Ii M, Sasajima J, Sugiyama Y, Nishikawa T, Nakano Y, Yanagawa N, Sato K, Maemoto A, Tanno S, Okumura T, Karasaki H, Kono T, Fujiya M, Ashida T, Chung DC, Kohgo Y.Sonic hedgehog derived from human pancreatic cancer cells augments angiogenic function of endothelial progenitor cells.Cancer Sci. 2008 Jun;99(6):1131-8.
  • Duerr EM, Mizukami Y, Ng A, Xavier RJ, Kikuchi H, Deshpande V, Warshaw AL, Glickman J, Kulke MH, Chung DC.Defining molecular classifications and targets in gastroenteropancreatic neuroendocrine tumors through DNA microarray analysis.Endocr Relat Cancer. 2008 Mar;15(1):243-56.
  • Stoffel EM, Ford B, Mercado RC, Punglia D, Kohlmann W, Conrad P, Blanco A, Shannon KM, Powell M, Gruber SB, Terdiman J, Chung DC, Syngal S.Sharing genetic test results in Lynch syndrome: communication with close and distant relatives.Clin Gastroenterol Hepatol. 2008 Mar;6(3):333-8.
  • Modlin IM, Oberg K, Chung DC, Jensen RT, de Herder WW, Thakker RV, Caplin M, Delle Fave G, Kaltsas GA, Krenning EP, Moss SF, Nilsson O, Rindi G, Salazar R, Ruszniewski P, Sundin A.Gastroenteropancreatic neuroendocrine tumours.Lancet Oncol. 2008 Jan;9(1):61-72. Review.
  • Park do Y, Sakamoto H, Kirley SD, Ogino S, Kawasaki T, Kwon E, Mino-Kenudson M, Lauwers GY, Chung DC, Rueda BR, Zukerberg LR.The Cables gene on chromosome 18q is silenced by promoter hypermethylation and allelic loss in human colorectal cancer.Am J Pathol. 2007 Nov;171(5):1509-19.
  • Manne SL, Chung DC, Weinberg DS, Vig HS, Catts Z, Cabral MK, Shannon K, Meropol NJ.Knowledge and attitudes about microsatellite instability testing among high-risk individuals diagnosed with colorectal cancer.Cancer Epidemiol Biomarkers Prev. 2007 Oct;16(10):2110-7.
  • Chung D, Ghossein RA, Lin O.Macrofollicular variant of papillary carcinoma: a potential thyroid FNA pitfall.Diagn Cytopathol. 2007 Sep;35(9):560-4.
  • Choi MY, Lauwers GY, Hur C, Willett CG, Chung DC.Microsatellite instability is frequently observed in rectal cancer and influenced by neoadjuvant chemoradiation.Int J Radiat Oncol Biol Phys. 2007 Aug 1;68(5):1584.
  • Chung DC, Yoon SS, Lauwers GY, Patel D.Case records of the Massachusetts General Hospital. Case 22-2007. A woman with a family history of gastric and breast cancer.N Engl J Med. 2007 Jul 19;357(3):283-91.
  • Kaurah P, MacMillan A, Boyd N, Senz J, De Luca A, Chun N, Suriano G, Zaor S, Van Manen L, Gilpin C, Nikkel S, Connolly-Wilson M, Weissman S, Rubinstein WS, Sebold C, Greenstein R, Stroop J, Yim D, Panzini B, McKinnon W, Greenblatt M, Wirtzfeld D, Fontaine D, Coit D, Yoon S, Chung D, Lauwers G, Pizzuti A, Vaccaro C, Redal MA, Oliveira C, Tischkowitz M, Olschwang S, Gallinger S, Lynch H, Green J, Ford J, Pharoah P, Fernandez B, Huntsman D.Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer.JAMA. 2007 Jun 6;297(21):2360-72.
  • Duerr EM, Chung DC.Molecular genetics of neuroendocrine tumors.Best Pract Res Clin Endocrinol Metab. 2007 Mar;21(1):1-14. Review.
  • Ruszniewski P, Delle Fave G, Cadiot G, Komminoth P, Chung D, Kos-Kudla B, Kianmanesh R, Hochhauser D, Arnold R, Ahlman H, Pauwels S, Kwekkeboom DJ, Rindi G, ,.Well-differentiated gastric tumors/carcinomas.Neuroendocrinology. 2006;84(3):158-64.
  • Kwak EL, Chung DC.Hereditary colorectal cancer syndromes: an overview.Clin Colorectal Cancer. 2007 Jan;6(5):340-4. Review.
  • Hur C, Chung DC, Schoen RE, Gazelle GS.The management of small polyps found by virtual colonoscopy: results of a decision analysis.Clin Gastroenterol Hepatol. 2007 Feb;5(2):237-44.
  • Herraiz M, Barbesino G, Faquin W, Chan-Smutko G, Patel D, Shannon KM, Daniels GH, Chung DC.Prevalence of thyroid cancer in familial adenomatous polyposis syndrome and the role of screening ultrasound examinations.Clin Gastroenterol Hepatol. 2007 Mar;5(3):367-73.
  • Bertagnolli MM, Eagle CJ, Zauber AG, Redston M, Solomon SD, Kim K, Tang J, Rosenstein RB, Wittes J, Corle D, Hess TM, Woloj GM, Boisserie F, Anderson WF, Viner JL, Bagheri D, Burn J, Chung DC, Dewar T, Foley TR, Hoffman N, Macrae F, Pruitt RE, Saltzman JR, Salzberg B, Sylwestrowicz T, Gordon GB, Hawk ET.Celecoxib for the prevention of sporadic colorectal adenomas.N Engl J Med. 2006 Aug 31;355(9):873-84.
  • Kirley SD, D'Apuzzo M, Lauwers GY, Graeme-Cook F, Chung DC, Zukerberg LR.The Cables Gene on Chromosome 18Q Regulates Colon Cancer Progression in Vivo.Cancer Biol Ther. 2005 Aug;4(8):861-3.
  • Hung KE, Chung DC.Colorectal cancer screening: today and tomorrow.South Med J. 2006 Mar;99(3):240-6; quiz 247-9. Review.
  • Mizukami Y, Fujiki K, Duerr EM, Gala M, Jo WS, Zhang X, Chung DC.Hypoxic regulation of vascular endothelial growth factor through the induction of phosphatidylinositol 3-kinase/Rho/ROCK and c-Myc.J Biol Chem. 2006 May 19;281(20):13957-63.
  • Gostjeva EV, Zukerberg L, Chung D, Thilly WG.Bell-shaped nuclei dividing by symmetrical and asymmetrical nuclear fission have qualities of stem cells in human colonic embryogenesis and carcinogenesis.Cancer Genet Cytogenet. 2006 Jan 1;164(1):16-24.
  • Syngal S, Stoffel E, Chung D, Willett C, Schoetz D, Schroy P, Jagadeesh D, Morel K, Ross M.Detection of stool DNA mutations before and after treatment of colorectal neoplasia.Cancer. 2006 Jan 15;106(2):277-83.
  • Jo WS, Mizukami Y, Duerr EM, Zukerberg LR, Chung DC.Wnt signaling can repress thrombospondin-1 expression in colonic tumorigenesis.Cancer Biol Ther. 2005 Dec;4(12):1361-6.
  • Willett CG, Boucher Y, Duda DG, di Tomaso E, Munn LL, Tong RT, Kozin SV, Petit L, Jain RK, Chung DC, Sahani DV, Kalva SP, Cohen KS, Scadden DT, Fischman AJ, Clark JW, Ryan DP, Zhu AX, Blaszkowsky LS, Shellito PC, Mino-Kenudson M, Lauwers GY.Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients.J Clin Oncol. 2005 Nov 1;23(31):8136-9.
  • Jo WS, Bandipalliam P, Shannon KM, Niendorf KB, Chan-Smutko G, Hur C, Syngal S, Chung DC.Correlation of polyp number and family history of colon cancer with germline MYH mutations.Clin Gastroenterol Hepatol. 2005 Oct;3(10):1022-8.
  • Mizukami Y, Jo WS, Duerr EM, Gala M, Li J, Zhang X, Zimmer MA, Iliopoulos O, Zukerberg LR, Kohgo Y, Lynch MP, Rueda BR, Chung DC.Induction of interleukin-8 preserves the angiogenic response in HIF-1alpha-deficient colon cancer cells.Nat Med. 2005 Sep;11(9):992-7.
  • Li J, Mizukami Y, Zhang X, Jo WS, Chung DC.Oncogenic K-ras stimulates Wnt signaling in colon cancer through inhibition of GSK-3beta.Gastroenterology. 2005 Jun;128(7):1907-18.
  • Kirley SD, Rueda BR, Chung DC, Zukerberg LR.Increased growth rate, delayed senescense and decreased serum dependence characterize cables-deficient cells.Cancer Biol Ther. 2005 Jun;4(6):654-8.
  • Costa-Guda J, Rosen ED, Jensen RT, Chung DC, Arnold A.Mutational analysis of PPARG as a candidate tumour suppressor gene in enteropancreatic endocrine tumours.Clin Endocrinol (Oxf). 2005 May;62(5):603-6.
  • Velayos FS, Allen BA, Conrad PG, Gum J, Kakar S, Chung DC, Truta B, Sleisenger MH, Kim YS, Terdiman JP.Low rate of microsatellite instability in young patients with adenomas: reassessing the Bethesda guidelines.Am J Gastroenterol. 2005 May;100(5):1143-9.
  • Zhang X, Gaspard JP, Mizukami Y, Li J, Graeme-Cook F, Chung DC.Overexpression of cyclin D1 in pancreatic beta-cells in vivo results in islet hyperplasia without hypoglycemia.Diabetes. 2005 Mar;54(3):712-9.
  • Jo WS, Chung DC.Genetics of hereditary colorectal cancer.Semin Oncol. 2005 Feb;32(1):11-23.
  • Chung DC.Cyclin D1 in human neuroendocrine: tumorigenesis.Ann N Y Acad Sci. 2004 Apr;1014:209-17.
  • Mizukami Y, Li J, Zhang X, Zimmer MA, Iliopoulos O, Chung DC.Hypoxia-inducible factor-1-independent regulation of vascular endothelial growth factor by hypoxia in colon cancer.Cancer Res. 2004 Mar 1;64(5):1765-72.
  • Willett CG, Boucher Y, di Tomaso E, Duda DG, Munn LL, Tong RT, Chung DC, Sahani DV, Kalva SP, Kozin SV, Mino M, Cohen KS, Scadden DT, Hartford AC, Fischman AJ, Clark JW, Ryan DP, Zhu AX, Blaszkowsky LS, Chen HX, Shellito PC, Lauwers GY, Jain RK.Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer.Nat Med. 2004 Feb;10(2):145-7.
  • Chung DC, Rustgi AK.The hereditary nonpolyposis colorectal cancer syndrome: genetics and clinical implications.Ann Intern Med. 2003 Apr 1;138(7):560-70.
  • Shattuck TM, Costa J, Bernstein M, Jensen RT, Chung DC, Arnold A.Mutational analysis of Smad3, a candidate tumor suppressor implicated in TGF-beta and menin pathways, in parathyroid adenomas and enteropancreatic endocrine tumors.J Clin Endocrinol Metab. 2002 Aug;87(8):3911-4.
  • Yoo LI, Chung DC, Yuan J.LKB1--a master tumour suppressor of the small intestine and beyond.Nat Rev Cancer. 2002 Jul;2(7):529-35.
  • Wu CL, Kirley SD, Xiao H, Chuang Y, Chung DC, Zukerberg LR.Cables enhances cdk2 tyrosine 15 phosphorylation by Wee1, inhibits cell growth, and is lost in many human colon and squamous cancers.Cancer Res. 2001 Oct 1;61(19):7325-32.
  • Zhang X, Gaspard JP, Chung DC.Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia.Cancer Res. 2001 Aug 15;61(16):6050-4.
  • Chung DC, Brown SB, Graeme-Cook F, Seto M, Warshaw AL, Jensen RT, Arnold A.Overexpression of cyclin D1 occurs frequently in human pancreatic endocrine tumors.J Clin Endocrinol Metab. 2000 Nov;85(11):4373-8.
  • Chung DC.The genetic basis of colorectal cancer: insights into critical pathways of tumorigenesis.Gastroenterology. 2000 Sep;119(3):854-65.
  • Nakata H, Wang SL, Chung DC, Westwick JK, Tillotson LG.Oncogenic ras induces gastrin gene expression in colon cancer.Gastroenterology. 1998 Nov;115(5):1144-53.
  • Chung DC, Brown SB, Graeme-Cook F, Tillotson LG, Warshaw AL, Jensen RT, Arnold A.Localization of putative tumor suppressor loci by genome-wide allelotyping in human pancreatic endocrine tumors.Cancer Res. 1998 Aug 15;58(16):3706-11.
  • Chung DC.Molecular prognostic markers and colorectal cancer: the search goes on.Gastroenterology. 1998 Jun;114(6):1330-2.
  • Chung DC, Smith AP, Louis DN, Graeme-Cook F, Warshaw AL, Arnold A.Analysis of the retinoblastoma tumour suppressor gene in pancreatic endocrine tumours.Clin Endocrinol (Oxf). 1997 Nov;47(5):523-8.
  • Chung DC, Smith AP, Louis DN, Graeme-Cook F, Warshaw AL, Arnold A.A novel pancreatic endocrine tumor suppressor gene locus on chromosome 3p with clinical prognostic implications.J Clin Invest. 1997 Jul 15;100(2):404-10.
  • Chung DC, Rustgi AK.DNA mismatch repair and cancer.Gastroenterology. 1995 Nov;109(5):1685-99.
  • Chung DC, Brand SJ, Tillotson LG.Mutually exclusive interactions between factors binding to adjacent Sp1 and AT-rich elements regulate gastrin gene transcription in insulinoma cells.J Biol Chem. 1995 Apr 14;270(15):8829-36.